863
Views
1
CrossRef citations to date
0
Altmetric
Articles

Curcumin inhibits invasion and metastasis of human hepatoma cells through Bclaf1-mediated Wnt/β-catenin signalling

, , , , , & show all
Pages 664-676 | Received 29 Jun 2022, Accepted 11 Aug 2022, Published online: 28 Aug 2022

References

  • Deldar Abad Paskeh, M., Mirzaei, S., Ashrafizadeh, M., Zarrabi, A., & Sethi, G. (2021). Wnt/β-catenin signaling as a driver of hepatocellular carcinoma progression: An emphasis on molecular pathways. Journal of Hepatocellular Carcinoma, 8, 1415–1444. https://doi.org/10.2147/JHC.S336858
  • Hu, X. Y., Hou, P. F., Li, T. T., Quan, H.-Y., Lin, T., Liu, J.-J., Bai, J., & Zheng, J.-N. (2018). The roles of Wnt/β-catenin signaling pathway related lncRNAs in cancer. International Journal of Biological Sciences, 14(14), 2003–2011. https://doi.org/10.7150/ijbs.27977
  • Jung, Y. S., Stratton, S. A., Lee, S. H., Kim, M., Jun, S., Zhang, J., Zheng, B., Cervantes, C. L., Cha, J., Barton, M. C., & Park, J. (2021). TMEM9-v-ATPase activates Wnt/β-catenin signaling via APC lysosomal degradation for liver regeneration and tumorigenesis. Hepatology, 73(2), 776–794. https://doi.org/10.1002/hep.31305
  • Kulik, L., & El-Serag, H. B. (2019). Epidemiology and management of hepatocellular carcinoma. Gastroenterology, 156(2), 477–491. https://doi.org/10.1053/j.gastro.2018.08.065
  • Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008). Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Letters, 269(2), 199–225. https://doi.org/10.1016/j.canlet.2008.03.009
  • Li, K., Xiao, K., Zhu, S., Wang, Y., & Wang, W. (2022). Chinese herbal medicine for primary liver cancer therapy: Perspectives and challenges. Frontiers in Pharmacology, 13, 889799. https://doi.org/10.3389/fphar.2022.889799
  • Li, M., Guo, T., Lin, J., Huang, X., Ke, Q., Wu, Y., Fang, C., & Hu, C. (2022). Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway. Journal of Ethnopharmacology, 283, 114689. https://doi.org/10.1016/j.jep.2021.114689
  • Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022). Wnt/β-catenin signalling: Function, biological mechanisms, and therapeutic opportunities. Signal Transduction and Targeted Therapy, 7(1), 3. https://doi.org/10.1038/s41392-021-00762-6
  • Liu, W., Yi, D. D., Guo, J. L., Xiang, Z.-X., Deng, L.-F., & He, L. (2015). Nuciferine, extracted from Nelumbo nucifera Gaertn, inhibits tumor-promoting effect of nicotine involving Wnt/β-catenin signaling in non-small cell lung cancer. Journal of Ethnopharmacology, 165, 83–93. https://doi.org/10.1016/j.jep.2015.02.015
  • Mou, S. J., Yang, P. F., Liu, Y. P., Xu, N., Jiang, W. W., & Yue, W. J. (2020). BCLAF1 promotes cell proliferation, invasion and drug-resistance though targeting lncRNA NEAT1 in hepatocellular carcinoma. Life Sciences, 242, 117177. https://doi.org/10.1016/j.lfs.2019.117177
  • Pan, Z., Zhuang, J., Ji, C., Cai, Z., Liao, W., & Huang, Z. (2018). Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression. Oncology Letters, 15(4), 4821–4826. https://doi.org/10.3892/ol.2018.7988
  • Peng, Y., Ao, M., Dong, B., Jiang, Y., Yu, L., Chen, Z., Hu, C., & Xu, R. (2021). Anti-Inflammatory effects of curcumin in the inflammatory diseases: Status, limitations and countermeasures. Drug Design, Development and Therapy, 15, 4503–4525. https://doi.org/10.2147/DDDT.S327378
  • Peng, Y. Y., He, Y. H., Chen, C., Xu, T., Li, L., Ni, M.-m., Meng, X.-m., Huang, C., & Li, J. (2016). NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. Cancer Letters, 376(1), 10–21. https://doi.org/10.1016/j.canlet.2016.03.006
  • Song, J., Zhou, H., Gu, D., & Xu, Y. (2022). Hepatocellular carcinoma differentiation: Research progress in mechanism and treatment. Frontiers in Oncology, 11, 790358. https://doi.org/10.3389/fonc.2021.790358
  • Wang, K., Qiu, X., Zhao, Y., Wang, H., & Chen, L. (2021). The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma. Cancer Biology and Medicine, 19(3), 305–318. https://doi.org/10.20892/j.issn.2095-3941.2021.0306
  • Wang, M., Jiang, S., Zhou, L., Yu, F., Ding, H., Li, P., Zhou, M., & Wang, K. (2019). Potential mechanisms of action of curcumin for cancer prevention: Focus on cellular signaling pathways and miRNAs. International Journal of Biological Sciences, 15(6), 1200–1214. https://doi.org/10.7150/ijbs.33710
  • Wang, S., Yu, S., Shi, W., Ge, L., Yu, X., Fan, J., & Zhang, J. (2011). Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life, 63(9), 775–782. https://doi.org/10.1002/iub.507
  • Wang, W., Smits, R., Hao, H., & He, C. (2019). Wnt/β-catenin signaling in liver cancers. Cancers, 11(7), 926. https://doi.org/10.3390/cancers11070926
  • Wen, Y., Zhou, X., Lu, M., He, M., Tian, Y., Liu, L., Wang, M., Tan, W., Deng, Y., Yang, X., Mayer, M. P., Zou, F., & Chen, X. (2019). Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma. Oncogene, 38(11), 1845–1859. https://doi.org/10.1038/s41388-018-0552-1
  • Xu, X. Y., Meng, X., Li, S., Gan, R. Y., Li, Y., & Li, H. B. (2018). Bioactivity, health benefits, and related molecular mechanisms of curcumin: Current progress, challenges, and perspectives. Nutrients, 10(10), 1553. https://doi.org/10.3390/nu10101553
  • Yang, J., Hainaut, P., Gores, G., Amadou, A., Plymoth, A., & Roberts, L. R. (2019). A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nature Reviews Gastroenterology & Hepatology, 16(10), 589–604. https://doi.org/10.1038/s41575-019-0186-y
  • Yu, F., Yu, C., Li, F., Zuo, Y., Wang, Y., Yao, L., Wu, C., Wang, C., & Ye, L. (2021). Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduction and Targeted Therapy, 6(1), 307. https://doi.org/10.1038/s41392-021-00701-5
  • Yu, Z., Zhu, J., Wang, H., Li, H., & Jin, X. (2022). Function of BCLAF1 in human disease. Oncology Letters, 23(2), 58. https://doi.org/10.3892/ol.2021.13176
  • Zhang, H., Zhang, W., Jiang, L., & Chen, Y. (2022). Recent advances in systemic therapy for hepatocellular carcinoma. Biomarker Research, 10(1), 3. https://doi.org/10.1186/s40364-021-00350-4
  • Zhang, M., Du, H., Wang, L., Yue, Y., Zhang, P., Huang, Z., Lv, W., Ma, J., Shao, Q., Ma, M., Liang, X., Yang, T., Wang, W., Zeng, J., Chen, G., Wang, X., & Fan, J. (2020). Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway. Chemico-Biological Interactions, 320, 109022. https://doi.org/10.1016/j.cbi.2020.109022
  • Zhang, S., Zhang, M., Chen, J., Zhao, J., Su, J., & Zhang, X. (2020). Ginsenoside compound K regulates HIF-1α-mediated glycolysis through Bclaf1 to inhibit the proliferation of human liver cancer cells. Frontiers in Pharmacology, 11, 583334. https://doi.org/10.3389/fphar.2020.583334
  • Zhou, X., Wen, Y., Tian, Y., He, M., Ke, X., Huang, Z., He, Y., Liu, L., Scharf, A., Lu, M., Zhang, G., Deng, Y., Yan, Y., Mayer, M. P., Chen, X., & Zou, F. (2019). Heat shock protein 90α-dependent B-cell-2-associated transcription factor 1 promotes hepatocellular carcinoma proliferation by regulating MYC proto-oncogene c-MYC mRNA stability. Hepatology, 69(4), 1564–1581. https://doi.org/10.1002/hep.30172